EdgarLookup

Hoth Therapeutics, Inc. — Insider Transactions

Form 4 filings by directors, officers, and 10%+ shareholders

SEC rules require corporate insiders — including directors, executive officers, and any shareholder owning more than 10% of a company's shares — to report changes in their ownership within two business days of a transaction. These disclosures are filed as Form 4. Open-market purchases (code P) are generally considered the most meaningful signal, as insiders are spending their own money.

Overview All Filings Annual Quarterly Insiders
Insider Title Type Shares Price Value Owns After Date
Knie Robb CEO and President Award / Grant 800,000 858,131 Aug 28, 2025
Knie Robb CEO and President Purchase 25,000 $0.67 $16,750 58,131 Aug 16, 2024
Pavell Jeff Award / Grant 5,075 5,075 Dec 13, 2022
Knie Robb CEO and President Purchase 10,000 $0.39 $3,900 828,259 Sep 19, 2022
Knie Robb CEO and President Purchase 10,000 $0.40 $4,000 818,259 Sep 16, 2022
AIkido Pharma Inc. Sale 400,000 $1.25 $500,000 1,130,674 May 26, 2020
Hayes Anthony Sale May 26, 2020
Hayes Anthony Sale 400,000 $1.25 $500,000 1,130,674 May 26, 2020
Knie Robb CEO and President Other 4 808,259 May 18, 2020
Linsley Wayne Award / Grant 3,333 3,333 Apr 15, 2020
Springer Graig Award / Grant 3,333 3,333 Apr 15, 2020
SPHERIX INC Other 9,226 1,636,230 Oct 28, 2019
Knie Robb CEO and President Other 85 808,255 Oct 28, 2019
Hayes Anthony Other 90,258 1,609,742 Oct 28, 2019
Poor Kevin Jess C 750,000 750,000 Feb 20, 2019
EITNER MATTHEW D. C 15,000 765,000 Feb 20, 2019